(VIANEWS) – The NYSE opens in less than two hours and Fresenius Medical Care AG‘s pre-market value is already 4.31% up.
Fresenius Medical Care AG’s last close was $21.80, 37.03% under its 52-week high of $34.62.
The last session, NYSE ended with Fresenius Medical Care AG (FMS) falling 2.59% to $21.80. NYSE dropped 0.45% to $15,582.94, after two sequential sessions in a row of losses, on what was a somewhat down trend trading session.
About Fresenius Medical Care AG
Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Earnings Per Share
As for profitability, Fresenius Medical Care AG has a trailing twelve months EPS of $1.28.
PE Ratio
Fresenius Medical Care AG has a trailing twelve months price to earnings ratio of 17.03. Meaning, the purchaser of the share is investing $17.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.08%.
Volume
Today’s last reported volume for Fresenius Medical Care AG is 798143 which is 42.3% below its average volume of 977952.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Fresenius Medical Care AG’s EBITDA is 61.26.
More news about Fresenius Medical Care AG (FMS).
